Malignant Transformation Initiated by Mll-AF9: Gene Dosage and Critical Target Cells
- 1 May 2008
- journal article
- Published by Elsevier in Cancer Cell
- Vol. 13 (5) , 432-440
- https://doi.org/10.1016/j.ccr.2008.03.005
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Unique and Independent Roles for MLL in Adult Hematopoietic Stem Cells and ProgenitorsCell Stem Cell, 2007
- Transformation from committed progenitor to leukaemia stem cell initiated by MLL–AF9Nature, 2006
- A murine Mll-AF4 knock-in model results in lymphoid and myeloid deregulation and hematologic malignancyBlood, 2006
- Genome-Wide Analysis of Menin Binding Provides Insights into MEN1 TumorigenesisPLoS Genetics, 2006
- Modulation of cell cycle by graded expression of MLL-AF4 fusion oncoproteinLeukemia, 2004
- Low expression of MDS1-EVI1–like-1 (MEL1) and EVI1-like-1 (EL1) genes in favorable-risk acute myeloid leukemiaExperimental Hematology, 2003
- Gene expression analysis of purified hematopoietic stem cells and committed progenitorsBlood, 2003
- Dendritic cell potentials of early lymphoid and myeloid progenitorsBlood, 2001
- Significance analysis of microarrays applied to the ionizing radiation responseProceedings of the National Academy of Sciences, 2001
- An Mll–AF9 Fusion Gene Made by Homologous Recombination Causes Acute Leukemia in Chimeric Mice: A Method to Create Fusion OncogenesCell, 1996